Mayssa Attar

1.3k total citations · 1 hit paper
34 papers, 971 citations indexed

About

Mayssa Attar is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mayssa Attar has authored 34 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Mayssa Attar's work include Glaucoma and retinal disorders (12 papers), Retinal Diseases and Treatments (11 papers) and Ocular Surface and Contact Lens (5 papers). Mayssa Attar is often cited by papers focused on Glaucoma and retinal disorders (12 papers), Retinal Diseases and Treatments (11 papers) and Ocular Surface and Contact Lens (5 papers). Mayssa Attar collaborates with scholars based in United States, Canada and Australia. Mayssa Attar's co-authors include Michael R. Robinson, Andrew Acheampong, Devin Welty, Joan-En Chang-Lin, Scott M. Whitcup, Baruch D. Kuppermann, Jie Shen, Nongnuj Tanphaichitr, John Sinclair and Richard D. Mamelok and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Mayssa Attar

34 papers receiving 933 citations

Hit Papers

Pharmacokinetics and Pharmacodynamics of a Sustained-Rele... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayssa Attar United States 13 566 351 188 158 76 34 971
Siew Kwan Koh Singapore 15 315 0.6× 230 0.7× 375 2.0× 261 1.7× 29 0.4× 29 865
Diane Tang‐Liu United States 15 341 0.6× 183 0.5× 312 1.7× 163 1.0× 192 2.5× 34 826
Allan J. Flach United States 16 982 1.7× 236 0.7× 305 1.6× 93 0.6× 52 0.7× 48 1.3k
Keith W. Ward United States 14 138 0.2× 97 0.3× 122 0.6× 124 0.8× 22 0.3× 19 584
Verney L. Sallee United States 11 205 0.4× 107 0.3× 54 0.3× 275 1.7× 56 0.7× 15 808
Kai Bruns Germany 13 345 0.6× 114 0.3× 177 0.9× 252 1.6× 16 0.2× 19 727
Jaeseong Oh South Korea 15 78 0.1× 58 0.2× 32 0.2× 194 1.2× 22 0.3× 84 723
B. A. John United States 11 73 0.1× 36 0.1× 50 0.3× 113 0.7× 26 0.3× 19 446
Béla Szende Hungary 16 18 0.0× 57 0.2× 40 0.2× 301 1.9× 7 0.1× 46 791
Pekka Suhonen Finland 14 76 0.1× 92 0.3× 124 0.7× 217 1.4× 226 3.0× 24 609

Countries citing papers authored by Mayssa Attar

Since Specialization
Citations

This map shows the geographic impact of Mayssa Attar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayssa Attar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayssa Attar more than expected).

Fields of papers citing papers by Mayssa Attar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayssa Attar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayssa Attar. The network helps show where Mayssa Attar may publish in the future.

Co-authorship network of co-authors of Mayssa Attar

This figure shows the co-authorship network connecting the top 25 collaborators of Mayssa Attar. A scholar is included among the top collaborators of Mayssa Attar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayssa Attar. Mayssa Attar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guymer, Robyn H., Philip J. Rosenfeld, Justis P. Ehlers, et al.. (2025). Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study. Experimental Eye Research. 255. 110340–110340. 2 indexed citations
2.
Jankovic, Joseph, Jean Carruthers, Markus Naumann, et al.. (2023). Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins. 15(5). 342–342. 16 indexed citations
3.
Callanan, David, Rahul N. Khurana, Raj K. Maturi, et al.. (2023). Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology. Volume 17. 1367–1384. 6 indexed citations
4.
Luu, Kenneth T., et al.. (2021). Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials. Journal of Pharmacology and Experimental Therapeutics. 378(3). 207–214. 11 indexed citations
5.
Luu, Kenneth T., et al.. (2020). A Mechanistic and Translational Pharmacokinetic-Pharmacodynamic Model of Abicipar Pegol and Vascular Endothelial Growth Factor Inhibition. Journal of Pharmacology and Experimental Therapeutics. 373(2). 184–192. 6 indexed citations
6.
Shen, Jie, Rex Moats, Harvey Pollack, Michael R. Robinson, & Mayssa Attar. (2020). Distribution of 14C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration. Ophthalmology and Therapy. 9(4). 929–940. 3 indexed citations
7.
Robinson, Michael R., et al.. (2018). Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues. Journal of Ocular Pharmacology and Therapeutics. 35(1). 50–57. 59 indexed citations
8.
Gore, Anu, et al.. (2017). Ocular emulsions and dry eye: a case study of a non-biological complex drug product delivered to a complex organ to treat a complex disease. Generics and Biosimilars Initiative Journal. 6(1). 13–23. 17 indexed citations
10.
Shen, Jie, Michael R. Robinson, & Mayssa Attar. (2016). Comparative Ocular Distribution of 14C-Latanoprost Following a Single Intracameral or Repeated Topical Ocular Dose in Dogs. Investigative Ophthalmology & Visual Science. 57(12). 5640–5640. 1 indexed citations
11.
Sebbag, Lionel, Shin Ae Park, Philip H. Kass, et al.. (2016). Assessment of tear film osmolarity using the TearLabosmometer in normal dogs and dogs with keratoconjunctivitis sicca. Veterinary Ophthalmology. 20(4). 357–364. 29 indexed citations
12.
Lee, Susan S., et al.. (2015). The effect of elevated intraocular pressure on convective flow in the vitreous. Investigative Ophthalmology & Visual Science. 56(7). 234–234. 1 indexed citations
13.
Attar, Mayssa, et al.. (2015). Evaluation of vitreous half-life and ocular distribution in rats, rabbits and monkeys after intravitreal administration of a novel biologic. Investigative Ophthalmology & Visual Science. 56(7). 221–221. 1 indexed citations
14.
Attar, Mayssa, et al.. (2013). Cross-Species and Cross-Age Comparison of Esterase Mediated Metabolism in Vitreous Humor: Human versus Rabbit, Dog and Monkey. Investigative Ophthalmology & Visual Science. 54(15). 5404–5404. 1 indexed citations
15.
Waterbury, L. David, Cathy Nguyen, Milan Patel, et al.. (2011). Ocular Penetration and Anti-inflammatory Activity of Ketorolac 0.45% and Bromfenac 0.09% Against Lipopolysaccharide-Induced Inflammation. Journal of Ocular Pharmacology and Therapeutics. 27(2). 173–178. 13 indexed citations
16.
Attar, Mayssa, et al.. (2005). Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters. Expert Opinion on Drug Delivery. 2(5). 891–908. 36 indexed citations
17.
Attar, Mayssa, et al.. (2005). Disposition and Biotransformation of the Acetylenic Retinoid Tazarotene in Humans. Journal of Pharmaceutical Sciences. 94(10). 2246–2255. 12 indexed citations
18.
Attar, Mayssa & Vincent H.L. Lee. (2003). Pharmacogenomic considerations in drug delivery. Pharmacogenomics. 4(4). 443–461. 8 indexed citations
19.
Attar, Mayssa, M. Kates, Maroun Bou Khalil, et al.. (2000). A Fourier-transform infrared study of the interaction between germ-cell specific sulfogalactosylglycerolipid and dimyristoylglycerophosphocholine. Chemistry and Physics of Lipids. 106(2). 101–114. 30 indexed citations
20.
Attar, Mayssa, et al.. (1998). Interaction between sulfogalactosylceramide and dimyristoylphosphatidylcholine increases the orientational fluctuation of their lipid hydrocarbon chains. Chemistry and Physics of Lipids. 94(2). 227–238. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026